Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses

Daniel J. Landsburg, Stefan K. Barta, Radhakrishnan Ramchandren, Connie Batlevi, Swaminathan Iyer, Kevin Kelly, Ivana N. Micallef, Sonali M. Smith, Don A. Stevens, Mariano Alvarez, Andrea Califano, Yao Shen, Gideon Bosker, Jefferson Parker, Raul Soikes, Elizabeth Martinez, Reinhard von Roemeling, Robert E. Martell, Yasuhiro Oki

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses'. Together they form a unique fingerprint.

Medicine & Life Sciences